3191 results for «2015»

Filter By

3191 results

China experience in TAVI evolution

22 May 2025 – From EuroPCR 2025

This session highlights key innovations and recent research from China in the field of transcatheter aortic valve implantation (TAVI). Leading cardiovascular specialist present new data on pacing strategies, comparing left bundle branch area pacing with traditional right ventricular pacing in TAVI patients. They also explore the use...

China experience in TAVI evolution

Mitral and tricuspid hotline: long-term outcomes

20 May 2025 – From EuroPCR 2025

Review long-term outcomes of transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valve disease in this session. Highlights include pivotal trial results, mortality risk prediction tools, management of procedural failures, and real-world data, providing comprehensive insights into patient prognosis and therapeutic impact.

Mitral and tricuspid hotline: long-term outcomes

AsiaIntervention is the official journal of the Asian-Pacific Society of Interventional Cardiology (APSIC) and the Interventional Cardiology Foundation of India (ICFI)

17 Sep 2018

Keen to see your work in the official journal of APSIC? Submit your manuscript now for a chance to see it featured among the great clinical research articles, expert reviews, case reports and images in cardiology!

AsiaIntervention: SUBMIT YOUR WORK

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry

25 Feb 2021

The study aimed to evaluate the validity of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria for East Asian patients undergoing contemporary percutaneous coronary intervention (PCI) from the PENDULUM registry.

Authors :

Masato Nakamura, Kazushige Kadota, Koichi Nakao, Yoshihisa Nakagawa, Junya Shite, Hiroyoshi Yokoi, Ken Kozuma, Kengo Tanabe, Raisuke Iijima, Atsushi Harada, Takeshi Kuroda, Yoshitaka Murakami
EuroIntervention: the PENDULUM registry

A short history of the Euro4C Group

16 Jan 2019

Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.

Euro4C Group

Another milestone achieved – Bentley sold its 300,000th BeGraft

07 Jun 2023

Biosensors International Announces Japanese PMDA Approval for BioFreedom™ Ultra and US FDA Approval for BioFreedom™

03 May 2022

iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation

04 Nov 2021

Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...

Nicola Ryan

Author

Nicola Ryan
iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Coronary sinus reducer for microvascular angina

28 Feb 2020

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

Coronary sinus reducer for microvascular angina

FDA approves US oriented clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft for treatment of aortic aneurysms CAUTION: Investigational device. Limited by United States law to investigational use.

28 Jun 2023

Bentley acquired the GoBack catheter

13 Sep 2022

BIOMAG-I clinical trial reaches primary endpoint at six month for unique next generation resorbable magnesium scaffold

23 Sep 2022

Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent

21 Jul 2022

Recruitment complete in BEVAR study for on-label use of the Bentley BeGraft peripheral PLUS as a bridging stent

10 Mar 2023

Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System

15 Feb 2022

Minimally invasive vs conventional sternotomy for mitral valve repair surgery: An expertise based multicentre randomised controlled trial (UK Mini Mitral)

07 Mar 2023

Reported from ACC 2023 / WCC

Edoardo Zancanaro provides his take on this clinical trial presented by Enoch Akowuah at the American College of Cardiology Scientific Session (ACC.23/WCC).

Edoardo Zancanaro

Author

Edoardo Zancanaro
Minimally invasive versus conventional sternotomy for mitral valve repair surgery: An expertise based multicentre randomised controlled trial (UK Mini Mitral)

Pursue Classics·Originality - Gusta® Balloon Seminar Salon:Beijing Station

22 Apr 2022

How to choose a snare and create a snare to enhance device trackability in structural interventions

19 Dec 2023

Transcatheter structural procedures are dramatically increasing in daily practice. Approaching hostile cardiac anatomy may increase the risk of device dislodgment and/or malposition. In such situations, the use of a snare catheter is pivotal to enhance device trackability.

Andrea Buono

Author

Andrea Buono

Author

Damiano Regazzoli
Diego Maffeo

Author

Diego Maffeo
Gabriele Gasparini

Author

Gabriele Gasparini
How to choose a snare and create a snare to enhance device trackability in structural interventions

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

Interventional management of an aortic root fistula after aortic-valve endocarditis

25 Jan 2021

This is a 44-year old male patient with an aortic root fistula to the right heart after past infective aortic valve endocarditis. Interventional shunt occlusion was successfully performed using a transcatheter closure device.

Interventional aortic root fistula closure
Didn’t find what you were looking for?